The Radioconjugates Strategy & Delivery Head supports end-to-end delivery of this new therapeutic modality from discovery to commercialization.
Base: $246,069.60 - $369,104.40; Bonus/Equity: short-term incentive bonus opportunity; equity-based long-term incentive program; Benefits: qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; health benefits
Must-have
Nice-to-have
Not specified